Large-scale collection of circulating haematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human GM-CSF
- 1 January 1990
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 26 (5) , 562-564
- https://doi.org/10.1016/0277-5379(90)90076-6
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1990
- Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factorBlood, 1989
- GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATIONThe Lancet, 1989
- Hematopoietic reconstitution using progenitors recovered from bloodTransfusion, 1989
- Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patientsBlood, 1988
- GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR EXPANDS THE CIRCULATING HAEMOPOIETIC PROGENITOR CELL COMPARTMENT IN MANThe Lancet, 1988
- Residual leukemia cannot be detected in very early remission peripheral blood stem cell collections in acute non-lymphoblastic leukemiaLeukemia Research, 1987
- Circulating autologous stem cells collected in very early remission from acute non‐lymphoblastic leukaemia produce prompt but incomplete haemopoietic reconstitution after high dose melphalan or supralethal chemoradiotherapyBritish Journal of Haematology, 1985
- Release of hemopoietic factors by normal human T cell lines with either suppressor or helper activityJournal of Cellular Physiology, 1985